Stock·NYSE·Consumer Cyclical
Cava Group, Inc. (CAVA)
- Market cap
- $6.69B
- P/E
- 104.09
- Dividend yield
- 0.00%
- Street target
- $85.00median of 28 analysts
- 52-week range
- $43.41 $98.79
The short version
Where CAVA stands today, in four lines, and what CleaRank Financial AI makes of it.
CAVA at a glance
Cava Group, Inc. (CAVA): Hold, 46/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($59.25 and $72.10).
- Earnings CAVA beat estimates in 6 of its last 8 quarters, yet fell the next day after 2 of those beats.
- Insiders Insiders sold $291.8M and bought $1.2M over the last 18 months.
- Valuation P/E of 104.1 against 20.8 for the Consumer Cyclical sector: a premium to peers (+400%).
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates Cava Group, Inc. (CAVA) Hold, with a model score of 46/100.
The analysts' outlook lifts the score most: 19 of 28 analysts rate it a buy and the median target is 48.5% above the price. The trend holds it back most: the price is 20.63% below its 200-day average and 3.40% below its 50-day average, and the 50-day average is 17.83% below the 200-day. The 50-day average stands at $59.25 and the 200-day at $72.10. Over the past year the price fell 9.64%.
Only on CleaRank
Figures we compute ourselves from CAVA's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $57.23 is 3.4% below the 50-day simple moving average of $59.25.Price above its 200-day average ›
The price is 20.6% below the 200-day simple moving average of $72.10.50-day average above the 200-day ›
The 50-day average ($59.25) is 17.8% below the 200-day average ($72.10), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 25% of its 52-week range, between $43.41 and $98.79.
CAVA share price
Pick a period: each tab shows how far CAVA has moved over it, to the last close.
Today's trading
Where CAVA sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
2/4P/E below the sector median ›
The trailing P/E of 104.09 is 400.4% above the Consumer Cyclical median of 20.8.P/S below the sector median ›
The price-to-sales ratio of 4.87 is 156.2% above the sector median of 1.9.Profitable over the last 12 months ›
Net income over the last 12 months was $66.3M on revenue of $1.4B, a net margin of 4.8%.Beat estimates in most recent reports ›
CAVA beat the EPS estimate in 6 of its last 8 reports.
Key statistics
The headline figures for CAVA.
As of October 17, 2026, CAVA trades at $57.23, with a market value of $6.69B and a P/E ratio of 104.09.
What the numbers say
CleaRank Financial AI's reading of CAVA's valuation, growth and risks.
CAVA trades at 104.09 times trailing earnings, which puts its P/E 400.4% above the Consumer Cyclical median of 20.8. The peer comparison on this page calls that a premium to peers. On sales, the P/S of 4.87 is 156.3% above the sector median P/S of 1.9.
In the latest year revenue grew 31.30%, 24.1 percentage points faster than the sector median of 7.2%. Margins stand at a net margin of 4.82% and an operating margin of 7.62%. Shareholders' capital earns 8.32%, below the sector median of 12.4%, measured as return on equity. Debt-to-equity of 0.62 rounds out the fundamentals.
The August 11, 2026 report beat expectations by 5.56%: EPS of $0.19 against an estimate of $0.18. The market agreed: the stock rose 14.24% the following session.
Over its last 8 reports, CAVA topped the estimate 6 times, but beats have not guaranteed gains: the stock fell the next day after 2 of them. Earlier, the stock rose 26.36% after the February 24, 2026 report, a beat of 33.33%. Looking ahead, analysts expect EPS of $0.5473 this fiscal year (growth of 1.4%) and $0.7424 the year after (growth of 35.6%).
Day-to-day volatility is the first thing to plan around: CAVA has moved 3.20% on an average session. Valuation leaves less margin for error: the P/E of 104.09 is 400.4% above the sector median, a premium to peers. The downtrend is itself a risk for as long as the price stays under both moving averages. The price is 42.07% below its 52-week high of $98.79.
CAVA against the Consumer Cyclical sector
How CAVA compares with the median Consumer Cyclical stock CleaRank tracks.
Price to earnings vs sector: CAVA trades at a significant premium to sector peers (+400%), suggesting market expectations for superior growth or market position.
Return vs SPY: Since May 6, 2025, CAVA has lost 38.7% against a gain of 36.6% for SPY.
Performance against SPY
CAVA and the Consumer Cyclical sector fund over the same days.
Revenue and earnings
How much CAVA sells, and how much of it becomes profit.
Revenue growth: Revenue grew 22.4% in FY2025 to $1.2B, from $964M a year earlier.
Profit margin: The net margin was 5.4% in FY2025, down from 13.5% the year before.
Profitable: CAVA earned $63.7M in FY2025.
Earnings reality check
Did CAVA beat what analysts expected, and how did the stock react?
Earnings record: CAVA beat the analyst estimate in 6 of the last 8 quarters.
Market reaction: The stock fell in the first session after 2 of those 6 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 11, 2026after close | $0.18 | $0.19 | +5.56% | +14.24% | +12.22% |
| Feb 24, 2026after close | $0.03 | $0.04 | +33.33% | +26.36% | +13.67% |
| Nov 4, 2025after close | $0.12 | $0.12 | +0.00% | -2.57% | -4.74% |
| Aug 12, 2025after close | $0.14 | $0.16 | +14.29% | -16.63% | -18.99% |
| May 15, 2025after close | $0.15 | $0.22 | +46.67% | -2.27% | -14.84% |
| Feb 25, 2025after close | $0.06 | $0.05 | -16.67% | -0.34% | -13.14% |
| Nov 12, 2024after close | $0.11 | $0.15 | +36.36% | +1.57% | -2.61% |
| Aug 22, 2024after close | $0.12 | $0.17 | +41.67% | +19.63% | +8.72% |
As of October 17, 2026, CAVA has beaten the analyst EPS estimate in 6 of its last 8 reported quarters and fell in the first trading session after 2 of those beats; its latest report, on August 11, 2026, came in 5.56% above the estimate and the stock moved +14.24% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 56.1, in neutral territory.RSI above 50 ›
An RSI of 56.1 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of CAVA
The score, the reasoning behind it, and what could move the price next.
Cava Group, Inc. (CAVA) is in a downtrend: both moving averages sit overhead. The price of $57.23 is 3.40% below its 50-day average of $59.25 and 20.63% below the 200-day average of $72.10. Sitting at 25% of its 52-week range, the price is 31.84% above the 52-week low of $43.41. The 50-day average is 17.83% below the 200-day, a gap that backs up the weakness rather than pushing against it.
Recent gains sit against a weaker longer record: the price rose 15.05% over the past month, fell 16.85% over the past three months and fell 9.64% over the past year. On momentum, the 14-day RSI reads 56.1, in the neutral zone, with the MACD line negative.
Earnings beat ›
The August 11, 2026 report beat the EPS estimate by 5.56%, and the share price rose 14.24% in the first session after it.
Source: Earnings report, August 11, 2026Analyst upgrade ›
Melius Research upgraded it to Buy from Hold on October 8, 2026.
Source: Analyst action, Melius Research, October 8, 2026
New analyst coverage ›
Seaport Global started coverage at Buy on September 16, 2026.
Source: Analyst action, Seaport Global, September 16, 2026
- Two levels matter most right now: the 50-day SMA at $59.25 sits above the price, and the 20-day EMA at $54.34 sits below it.
- The 14-day RSI is 56.1, which is neutral, and the MACD line is negative. Readings above 70 or below 30 would signal stretched momentum.
- The share price rose 14.24% in the first session after the August 11, 2026 report. CAVA has beaten estimates in 6 of the last 8 reports.
CAVA remains in a downtrend while it trades under both its 50-day average of $59.25 and its 200-day average of $72.10. A close above the 50-day would be the first sign of a recovery. The 50-day SMA, at $59.25, is the first barrier above the current price.
To the downside, the first level under the price is the 20-day EMA, at $54.34.
Technical indicators
Momentum and trend for CAVA, from its daily closes.
As of October 17, 2026, with CAVA at $57.23, its 14-day RSI is 56.1 (neutral territory), its 50-day simple moving average is $59.25 and its 200-day is $72.10.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What CAVA moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, CAVA's 1-year correlation of daily returns is +0.45 with S&P 500 (SPY), +0.42 with Nasdaq 100 (QQQ), +0.23 with Bitcoin (BTC) and +0.08 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
19 of 28 analysts rate it a buy or strong buy, 8 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $85.00 is 48.5% above the price.More buy ratings than three months ago ›
19 of 28 rate it a buy now, against 18 of 27 three months ago.
CAVA Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 8, 2026 | Melius Research | Upgrade | Buy |
| Sep 18, 2026 | JP Morgan | Maintains | Overweight |
| Sep 17, 2026 | RBC Capital | Maintains | Outperform |
| Sep 16, 2026 | Seaport Global | Initiates | Buy |
| Aug 13, 2026 | DA Davidson | Maintains | Neutral |
| Aug 13, 2026 | Guggenheim | Maintains | Buy |
As of October 17, 2026, 28 Wall Street analysts cover CAVA: 19 rate it a buy or strong buy, 8 a hold and 1 a sell or strong sell. Their 12-month price targets range from $18.00 to $110.00, with a median of $85.00, 48.5% above the price of $57.23.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
CAVA trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
CAVA moves about 3.2% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much CAVA tends to move, against the market and on its own.
The long record
CAVA's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move under 2% ›
The price has moved 3.20% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 71.1%, from December 2024 to November 2025; the price is still 62.1% below that peak.Most 1-year holds ended higher ›
50% of 1-year holding periods in the last 3 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in June 2023 is now worth $15,001, against $18,072 in the S&P 500 (SPY).
CAVA Drawdowns & Recovery
As of October 17, 2026, CAVA's worst peak-to-trough fall over the last 3 years with dividends reinvested was -71.1% (December 2024 to November 2025); it is still 62.1% below that peak, and 50% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into CAVA in June 2023 is worth now, against the same amount in the S&P 500.
Against the market: CAVA trailed the S&P 500 over this period: $15,001 against $18,072.
A $10,000 investment in CAVA in June 2023 would be worth about $15,001 today with dividends reinvested, compared with about $18,072 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to CAVA, and which have not.
Strongest month, January: an average of +11.28%, up in 3 of 3 years.
Weakest month, September: an average of -12.69%, up in 1 of 4 years.
This month, October: has averaged -2.09%, up in 2 of 3 years. Past seasonality does not repeat on schedule.
Over the last 4 years, CAVA's strongest calendar month has been January (average +11.28%, up in 3 of 3 years) and its weakest September (average -12.69%, up in 1 of 4 years).
Average return for each calendar month over the last 4 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in CAVA, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in CAVA today could grow to about $21,953 by 2036 in the base case, with a 90th-percentile outcome near $166,548 and a 10th-percentile outcome around $2,894. Projections are statistical simulations, not guarantees.
CAVA Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $78.38 for CAVA by 2030 in the base case, from $57.23 today (1.4x over 4 years). The 10th-percentile path ends near $21.76. These are outcomes of a Monte Carlo simulation run on CAVA's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $32.62 | $61.91 | $118 | |
| 2028 | $27.06 | $66.98 | $166 | |
| 2029 | $23.88 | $72.46 | $220 | |
| 2030 | $21.76 | $78.38 | $282 | |
| 2031 | $20.23 | $84.79 | $355 |
Method: a lognormal simulation of CAVA's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
CAVA insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $1.2M on the open market and sold $291.8M.
As of October 17, 2026, CAVA insiders reported 36 open-market sales worth $291.8M and 7 open-market purchases worth $1.2M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | Joseph John Kadow
Officer
|
Buy | 1.0K | $50.0K |
| Sep 9, 2026 | Theodoros Xenohristos
Officer and Director
|
Grant | 16.5K | - |
| Aug 31, 2026 | Douglas W Thompson
Chief Operating Officer
|
Buy | 6.5K | $432.4K |
| Aug 13, 2026 | Amiee Lynn Thomas
Director
|
Grant | 1.8K | - |
| Jun 22, 2026 | Philippe Amouyal
Director
|
Grant | 1.9K | - |
| Jun 22, 2026 | David Bosserman
Director
|
Grant | 1.9K | - |
| Jun 22, 2026 | Benjamin Felt
Director
|
Grant | 1.9K | - |
| Jun 22, 2026 | Ronald M Shaich
Director
|
Grant | 1.9K | - |
| Jun 22, 2026 | Lauri M. Shanahan
Director
|
Grant | 1.9K | - |
| Jun 22, 2026 | James D White
Director
|
Grant | 1.9K | - |
| Jun 18, 2026 | Karen Kochevar
Director
|
Sell | 10.0K | $900.0K |
| Jun 18, 2026 | Karen Kochevar
Director
|
Option | 10.0K | $67.1K |
| Jun 17, 2026 | Kelly Costanza
Officer
|
Sell | 15.4K | $1.4M |
| Jun 15, 2026 | Participations S.a.r.l. Artal
Unknown
|
Sell | 3.0M | $270.9M |
| Jun 15, 2026 | Brett M Schulman
Chief Executive Officer
|
Sell | 33.2K | $3.0M |
| Jun 15, 2026 | Patricia K Tolivar
Chief Financial Officer
|
Sell | 5.0K | $444.4K |
| Jun 15, 2026 | Theodoros Xenohristos
Officer and Director
|
Sell | 3.3K | $290.8K |
| Jun 15, 2026 | Adam David Phillips
Officer
|
Sell | 757 | $67.7K |
| Jun 15, 2026 | Patricia K Tolivar
Chief Financial Officer
|
Grant | 283 | $25.3K |
| Jun 12, 2026 | Adam David Phillips
Officer
|
Sell | 4.7K | $423.1K |
| Jun 12, 2026 | Adam David Phillips
Officer
|
Option | 2.8K | $60.8K |
| Jun 3, 2026 | Joseph John Kadow
Officer
|
Buy | 1.0K | $70.0K |
| May 29, 2026 | Joseph John Kadow
Officer
|
Buy | 1.0K | $79.0K |
| May 29, 2026 | Douglas W Thompson
Chief Operating Officer
|
Buy | 2.5K | $194.8K |
| May 26, 2026 | Douglas W Thompson
Chief Operating Officer
|
Buy | 4.0K | $317.8K |
| May 21, 2026 | Kelly Costanza
Officer
|
Sell | 10.0K | $799.5K |
| May 21, 2026 | Adam David Phillips
Officer
|
Sell | 5.2K | $399.7K |
| May 21, 2026 | Adam David Phillips
Officer
|
Option | 5.2K | $49.6K |
| May 11, 2026 | Theodoros Xenohristos
Officer and Director
|
Sell | 9.0K | $721.3K |
| Mar 5, 2026 | Kenneth Robert Bertram
Officer
|
Sell | 15.0K | $1.2M |
| Feb 26, 2026 | Kelly Costanza
Officer
|
Sell | 31.8K | $2.7M |
| Feb 26, 2026 | Adam David Phillips
Officer
|
Sell | 2.0K | $171.1K |
| Feb 26, 2026 | Kenneth Robert Bertram
Officer
|
Grant | 3.8K | - |
| Feb 26, 2026 | Kelly Costanza
Officer
|
Option | 31.8K | $214.7K |
| Feb 26, 2026 | Kelly Costanza
Officer
|
Grant | 4.7K | - |
| Feb 26, 2026 | Adam David Phillips
Officer
|
Grant | 1.1K | - |
| Feb 26, 2026 | Brett M Schulman
Chief Executive Officer
|
Grant | 29.1K | - |
| Feb 26, 2026 | Patricia K Tolivar
Chief Financial Officer
|
Grant | 8.0K | - |
| Feb 26, 2026 | Theodoros Xenohristos
Officer and Director
|
Grant | 4.7K | - |
| Jan 27, 2026 | Brett M Schulman
Chief Executive Officer
|
Sell | 4.5K | $282.3K |
| Jan 27, 2026 | Patricia K Tolivar
Chief Financial Officer
|
Sell | 2.4K | $149.4K |
| Jan 27, 2026 | Kelly Costanza
Officer
|
Sell | 1.7K | $106.1K |
| Jan 27, 2026 | Theodoros Xenohristos
Officer and Director
|
Sell | 1.0K | $64.6K |
| Jan 27, 2026 | Kenneth Robert Bertram
Officer
|
Sell | 994 | $61.8K |
| Jan 27, 2026 | Adam David Phillips
Officer
|
Sell | 774 | $48.1K |
| Jan 21, 2026 | Brett M Schulman
Chief Executive Officer
|
Sell | 21.7K | $1.5M |
| Jan 21, 2026 | Patricia K Tolivar
Chief Financial Officer
|
Sell | 2.2K | $148.6K |
| Jan 21, 2026 | Kelly Costanza
Officer
|
Sell | 1.7K | $114.7K |
| Jan 21, 2026 | Kenneth Robert Bertram
Officer
|
Sell | 1.1K | $72.4K |
| Jan 21, 2026 | Theodoros Xenohristos
Officer and Director
|
Sell | 965 | $65.1K |
| Dec 15, 2025 | Kenneth Robert Bertram
Officer
|
Grant | 47 | $2.1K |
| Nov 26, 2025 | Kenneth Robert Bertram
Officer
|
Sell | 3.8K | $192.1K |
| Nov 12, 2025 | Brett M Schulman
Chief Executive Officer
|
Buy | 150 | $7.3K |
| Nov 10, 2025 | Brett M Schulman
Chief Executive Officer
|
Option | 36.7K | $212.4K |
| Sep 29, 2025 | Kenneth Robert Bertram
Officer
|
Sell | 3.8K | $222.0K |
| Sep 18, 2025 | Theodoros Xenohristos
Officer and Director
|
Grant | 16.0K | - |
| Jun 20, 2025 | Philippe Amouyal
Director
|
Grant | 1.8K | - |
| Jun 20, 2025 | David Bosserman
Director
|
Grant | 1.8K | - |
| Jun 20, 2025 | Benjamin Felt
Director
|
Grant | 1.8K | - |
| Jun 20, 2025 | Karen Kochevar
Director
|
Grant | 1.8K | - |
| Jun 20, 2025 | Ronald M Shaich
Director
|
Grant | 1.8K | - |
| Jun 20, 2025 | Lauri M. Shanahan
Director
|
Grant | 1.8K | - |
| Jun 20, 2025 | James D White
Director
|
Grant | 1.8K | - |
| Jun 16, 2025 | Brett M Schulman
Chief Executive Officer
|
Sell | 31.9K | $2.4M |
| Jun 16, 2025 | Patricia K Tolivar
Chief Financial Officer
|
Sell | 4.8K | $364.1K |
| Jun 16, 2025 | Theodoros Xenohristos
Officer and Director
|
Sell | 3.1K | $230.1K |
| Jun 16, 2025 | Jennifer Somers
Officer
|
Sell | 2.9K | $215.0K |
| Jun 16, 2025 | Kelly Costanza
Officer
|
Sell | 2.8K | $210.4K |
| Jun 16, 2025 | Kenneth Robert Bertram
Officer
|
Sell | 2.2K | $165.2K |
| Jun 16, 2025 | Adam David Phillips
Officer
|
Sell | 739 | $55.5K |
| Jun 16, 2025 | Kenneth Robert Bertram
Officer
|
Grant | 169 | $10.7K |
| Jun 16, 2025 | Adam David Phillips
Officer
|
Grant | 146 | $9.3K |
| Jun 16, 2025 | Jennifer Somers
Chief Operating Officer
|
Grant | 133 | $8.4K |
| Jun 16, 2025 | Patricia K Tolivar
Chief Financial Officer
|
Grant | 197 | $12.5K |
| May 21, 2025 | Kelly Costanza
Officer
|
Sell | 10.2K | $887.4K |
| May 9, 2025 | Theodoros Xenohristos
Officer and Director
|
Sell | 9.3K | $887.0K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.